Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

Clinical trial NCT06589609 · RECRUITING

Trial details

NCT number: NCT06589609
Sponsor: BlueSky Immunotherapies GmbH
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Oropharyngeal Squamous Cell Carcinoma (SCC)

Start date: 2024-08-23
Primary completion: 2027-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.